Skip to main content

Jacobs John C's Form 4 filing

Harmony Biosciences Holdings, Inc. (HRMY) · filed Aug 16, 2022

Accession no.
0001415889-22-008696
Filed
Aug 16, 2022
Trade date
Aug 15, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $2.04M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Jacobs John CCIK 0001820836Director, Officer (PRESIDENT, CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 15, 2022Common StockMOption exerciseAcquired+40,000$8.22+$328,80040,000Direct
Aug 15, 2022Common StockSSaleDisposed−39,091$51.05−$1,995,595.55909Direct
Aug 15, 2022Common StockSSaleDisposed−909$51.76−$47,049.840Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 15, 2022Common StockMOption exerciseDisposed−40,000$0.00$0114,751Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)